| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.BIOMATERIALS.2016.07.005 |
| P8608 | Fatcat ID | release_frhdg2ygqjarfpqg6s3kjx6qqm |
| P932 | PMC publication ID | 4993816 |
| P698 | PubMed publication ID | 27475727 |
| P50 | author | Julie T-W Wang | Q84884454 |
| P2093 | author name string | Sandra S Diebold | |
| Giovanna Lombardi | |||
| Khuloud T Al-Jamal | |||
| Lesley Smyth | |||
| Kulachelvy Ratnasothy | |||
| Pedro M Costa | |||
| Hatem A F M Hassan | |||
| P2860 | cites work | Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles | Q39742676 |
| Carbon nanotubes conjugated to tumor lysate protein enhance the efficacy of an antitumor immunotherapy | Q39948212 | ||
| Potent antigen-specific immune responses stimulated by codelivery of CpG ODN and antigens in degradable microparticles | Q40115865 | ||
| Carbon nanotubes as intracellular transporters for proteins and DNA: an investigation of the uptake mechanism and pathway | Q40340698 | ||
| Immunostimulatory DNA-based vaccines induce cytotoxic lymphocyte activity by a T-helper cell-independent mechanism | Q41734956 | ||
| CD40-targeted dendritic cell delivery of PLGA-nanoparticle vaccines induce potent anti-tumor responses | Q41736997 | ||
| Dendritic cell-targeted vaccines--hope or hype? | Q42696952 | ||
| Multi-walled carbon nanotubes conjugated to tumor protein enhance the uptake of tumor antigens by human dendritic cells in vitro | Q42908570 | ||
| Antigen co-encapsulated with adjuvants efficiently drive protective T cell immunity | Q43883594 | ||
| TLR ligands and antigen need to be coencapsulated into the same biodegradable microsphere for the generation of potent cytotoxic T lymphocyte responses | Q44997831 | ||
| Systemic activation of dendritic cells by Toll-like receptor ligands or malaria infection impairs cross-presentation and antiviral immunity | Q45264704 | ||
| T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions | Q47982736 | ||
| Help for cytotoxic-T-cell responses is mediated by CD40 signalling | Q47982749 | ||
| The devil and holy water: protein and carbon nanotube hybrids. | Q50858370 | ||
| A carbon nanotube-polymer composite for T-cell therapy. | Q53482969 | ||
| Oxidized multiwalled carbon nanotubes as antigen delivery system to promote superior CD8(+) T cell response and protection against cancer | Q57162793 | ||
| Engagement of CD40 antigen with soluble CD40 ligand up-regulates peptide transporter expression and restores endogenous processing function in Burkitt's lymphoma cells | Q58423451 | ||
| Toll-dependent selection of microbial antigens for presentation by dendritic cells | Q59063722 | ||
| DNA-assisted dispersion and separation of carbon nanotubes | Q73263504 | ||
| Effective induction of CD8+ T-cell response using CpG oligodeoxynucleotides and HER-2/neu-derived peptide co-encapsulated in liposomes | Q73520517 | ||
| Analysis of the oligomeric requirement for signaling by CD40 using soluble multimeric forms of its ligand, CD154 | Q74602347 | ||
| Toll-like receptor recognition regulates immunodominance in an antimicrobial CD4+ T cell response | Q79135233 | ||
| Cationic carbon nanotubes bind to CpG oligodeoxynucleotides and enhance their immunostimulatory properties | Q81228461 | ||
| Cellular uptake of functionalized carbon nanotubes is independent of functional group and cell type | Q81697625 | ||
| Internalization and endosomal degradation of receptor-bound antigens regulate the efficiency of cross presentation by human dendritic cells | Q84569562 | ||
| Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation | Q24677534 | ||
| CD40-CD40 ligand | Q28143324 | ||
| Carbon nanotubes' surface chemistry determines their potency as vaccine nanocarriers in vitro and in vivo | Q28388765 | ||
| Liposomal co-entrapment of CD40mAb induces enhanced IgG responses against bacterial polysaccharide and protein | Q28472828 | ||
| Cancer immunotherapy via dendritic cells | Q29615444 | ||
| Microenvironmental regulation of tumor progression and metastasis | Q29615504 | ||
| Uptake and transport of PEG-graft-trimethyl-chitosan copolymer-insulin nanocomplexes by epithelial cells | Q33223560 | ||
| Synergistic augmentation of CD40-mediated activation of antigen-presenting cells by amphiphilic poly(γ-glutamic acid) nanoparticles | Q34300294 | ||
| Antibody-antigen-adjuvant conjugates enable co-delivery of antigen and adjuvant to dendritic cells in cis but only have partial targeting specificity | Q34341859 | ||
| Carbon nanotubes enhance CpG uptake and potentiate antiglioma immunity | Q34586673 | ||
| Distinct pathways of antigen uptake and intracellular routing in CD4 and CD8 T cell activation. | Q34623431 | ||
| CD40/CD154 interactions at the interface of tolerance and immunity | Q35698455 | ||
| Biomedical applications of functionalised carbon nanotubes | Q36020728 | ||
| Intracerebral CpG immunotherapy with carbon nanotubes abrogates growth of subcutaneous melanomas in mice | Q36353528 | ||
| Induction of a CD8+ cytotoxic T lymphocyte response by cross-priming requires cognate CD4+ T cell help | Q36380318 | ||
| Multivalent porous silicon nanoparticles enhance the immune activation potency of agonistic CD40 antibody | Q36452648 | ||
| Antigen delivery to early endosomes eliminates the superiority of human blood BDCA3+ dendritic cells at cross presentation | Q36822696 | ||
| Toll-like receptor 9 (TLR9) agonists in the treatment of cancer | Q37050998 | ||
| In vivo studies on the effect of co-encapsulation of CpG DNA and antigen in acid-degradable microparticle vaccines | Q37317946 | ||
| Targeting Toll-like receptors: emerging therapeutics? | Q37727910 | ||
| Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns | Q37800358 | ||
| Combination cancer immunotherapies tailored to the tumour microenvironment | Q38645178 | ||
| The uptake and intracellular fate of PLGA nanoparticles in epithelial cells | Q38731626 | ||
| Gold nanocluster-based vaccines for dual-delivery of antigens and immunostimulatory oligonucleotides | Q38858337 | ||
| P921 | main subject | immunotherapy | Q1427096 |
| carbon nanotube | Q1778729 | ||
| P304 | page(s) | 310-322 | |
| P577 | publication date | 2016-07-14 | |
| P1433 | published in | Biomaterials | Q15751139 |
| P1476 | title | Dual stimulation of antigen presenting cells using carbon nanotube-based vaccine delivery system for cancer immunotherapy | |
| P478 | volume | 104 |
| Q90357670 | Current applications and future prospects of nanotechnology in cancer immunotherapy |
| Q64272058 | Emerging Nano-/Microapproaches for Cancer Immunotherapy |
| Q95327672 | Harnessing nanomedicine to overcome the immunosuppressive tumor microenvironment |
| Q57492118 | Interactions Between Nanoparticles and Dendritic Cells: From the Perspective of Cancer Immunotherapy |
| Q28072532 | Is There Still Room for Cancer Vaccines at the Era of Checkpoint Inhibitors |
| Q89163976 | Mapping of the available standards against the regulatory needs for nanomedicines |
| Q91924133 | Nanoparticle systems for cancer vaccine |
| Q39236622 | Recent advances in carbon based nanosystems for cancer theranostics. |
| Q99413714 | The sixth revolution in pediatric vaccinology: immunoengineering and delivery systems |
| Q55004711 | Utilizing the nanosecond pulse technique to improve antigen intracellular delivery and presentation to treat tongue squamous cell carcinoma. |
Search more.